Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Heart & Lung : the Journal of Critical Care|January 22, 2008
Clinical exacerbations as a surrogate end point in heart failure researchSteven L Sayers, Barbara Riegel, Lee R Goldberg, et al.
Journal of the American College of Cardiology|May 22, 2002
Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VANQWISH trialAbhinav Goyal, Frederick F Samaha, William E Boden, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Adipocytokine changes caused by low-carbohydrate compared to conventional diets in obesityPrakash Seshadri, Frederick F Samaha, Linda Stern, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 12, 2005
Free fatty acids, insulin resistance, and corrected qt intervals in morbid obesity: effect of weight loss during 6 months with differing dietary interventionsPrakash Seshadri, Frederick F Samaha, Linda Stern, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 6, 2005
Density of platelet collagen receptors glycoprotein VI and alpha2beta1 and prior myocardial infarction in human subjects, a pilot studyFrederick F Samaha, Christopher Hibbard, Jay Sacks, et al.
Pharmacogenomics|February 28, 2007
Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivityCarmel Kealey, Zhen Chen, Jason Christie, et al.
The Journal of Biological Chemistry|April 8, 2004
Functional polymorphism in the carboxyl terminus of the alpha-subunit of the human epithelial sodium channelFrederick F Samaha, Ronald C Rubenstein, Wusheng Yan, et al.
Annals of Internal Medicine|May 19, 2004
The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trialLinda Stern, Nayyar Iqbal, Prakash Seshadri, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2005
Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndromeFrederick F Samaha, Philippe O Szapary, Nayyar Iqbal, et al.
Pageof 3